Search
Categories


Posts Tagged ‘Shows’

Tadalafil shows improvement in LUTS; benefit unexplained by urodynamic effects

Monday, May 31st, 2010

Findings from a multicenter, double-blind, placebo-controlled study are consistent with previously
reported data showing that tadalafil (Cialis) improves lower urinary tract symptoms associated with BPH. However,
the benefit cannot be explained by effects on pressure-flow urodynamics. (Source: Modern Medicine)

Erectile Dysfunction Drug Shows Promise For Relief Of Lower Urinary Tract Symptoms Associated With Benign Prostate Disease

Sunday, May 30th, 2010

Men with signs of be nign prostatic hyperplasia can be helped with a daily dose of erectile dysfunction drug tadalafil (marketed as Cialis) to relieve associated lower urinary tract symptoms, according to a new study. Researchers from the University of Texas Southwestern Medical Center at Dallas, Northwestern University and Lilly Research Laboratories report on a randomized, double-blind, placebo-controlled study of over 1,000 men in 10 countries. (more…)

New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol

Sunday, May 30th, 2010

The first prospective trial specifically designed to evaluate erectile function in ED patients with dyslipidemia

CHICAGO, Dec. 10 (HSMN NewsFeed) — Results of the first prospective trial specifically designed to evaluate erectile function in erectile… BiopharmaceuticalsSchering-Plough, erectile dysfunction, LEVITRA, vardenafil, dyslipidemia (Source: HSMN NewsFeed)

Study shows male erectile dysfunction drug enhances fetal growth in female sheep

Friday, May 28th, 2010

(Texas A&M Agri Life Communications) Viagra (sildenafil citrate), which is used to treat male erectile dysfunction, enhanced blood flow in pregnant female sheep, helping send vital amino acids and other nutrients needed in fetal development. The study’s results not only will assist with solving fetal development problems in other livestock, but possibly in humans. (Source: EurekAlert! – Medicine and Health)

Topical Erectile Dysfunction Therapy Shows Promise

Monday, May 24th, 2010

This study was done to evaluate whether the Einstein nanoparticles, which have been shown to penetrate the skin, might allow the targeted delivery of compounds that treat ED and thereby avoid the drugs’ systemic effect s.

An effective topical therapy could be especially significant for those ED patients – particularly men with diabetes – who have reduced levels of nitric oxide (NO), the signaling molecule that dilates blood vessels (more…)

Levitra May Protect The Heart, VCU Study Shows

Sunday, May 23rd, 2010

The widely used erectile dysfunction drug Levitra is now the second drug in its class found to protect the heart against tissue damage following acute heart attack, according to a new study by Virginia Commonwealth University researchers. [click link for full article] (Source: Erectile Dysfunction / Premature Ejaculation News From Med ical News Today)

Judge Says Echo Shows Regurgitation Before Aortic Surgery

Saturday, May 22nd, 2010

PHILADELPHIA – An echocardiogram taken during surgery to replace a former diet drug user’s aortic valv e shows her level of regurgitation before surgery, entitling her to benefits, the judge supervising the American Home Products National Settlement has ruled (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. (more…)

New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) In Men With Dyslipidemia, Including High Cholesterol

Friday, May 21st, 2010

Results of the first prospective trial specifically designed to evaluate erectile function in erectile dysfunction (ED) patients with dyslipidemia show that LEVITRA(R) (vardenafil HCl), used in treating ED, significantly improves the ability of men with ED and dyslipidemia to achieve and maintain an erection for successful sexual intercourse. These data were presented at the Sexual Medicine Society of North America (SMSNA) Fall Meeting held in (more…)

Oral ED agent has rapid onset of action, study shows

Friday, May 14th, 2010

Buenos Aires, Argentina–The onset of action may be very rapid within 10 minutes in some men who take
vardenafil (Levitra) to treat erectile dysfunction, according to the results of a multinational
study. (Source: Ur ologyTimes – Sexual Dysfunction)

MedWorm Message: Register forMedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Tadalafil Shows Promise for Relief of Lower Urinary Tract Symptoms Associated With BPH

Friday, March 26th, 2010

NEW YORK, August 19, 2008 – Men with signs of benign prostatic hyperplasia (BPH) can be helped with a daily dose of erectile dysfunction drug tadalafil (Cialis) to relieve associated lower urinary tract symptoms (LUTS), according to a new… (Source: Drugs.com – Pharma News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of a uthoritative health and news (more…)

Page 1 of 3123